Intended Use

Diagnostic ultrasound imaging and fluid flow analysis of the human body for multiple body regions including abdominal, cardiac, cerebral vascular, musculoskeletal, ophthalmic, lung, breast, and others. It can be used in clinics, hospitals, and point-of-care settings, supporting diagnosis and treatment guidance.

Technology

The device includes a 2500 element phased array 3D transesophageal cardiac transducer operating at 4-11 MHz, supported on multiple EPIQ system platforms running software version 11.0 or higher. It performs pulsed Doppler and pulsed echo imaging for diagnostic purposes and can integrate with EchoNavigator for live X-ray and ultrasound image guidance in cardiovascular procedures.

Performance

The system complies with multiple international standards for medical electrical equipment, electromagnetic compatibility, ultrasound safety, and biological evaluation. Non-clinical performance testing includes system-level requirements verification, risk management, design reviews, and bench testing. Clinical data were not required due to the demonstrated substantial equivalence to predicate devices.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    11/3/2023

    27 days
  • 2

    FDA Approval

    11/30/2023

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.